Topics

FANATREX | Fanatrex [California Pharmaceuticals LLC] | BioPortfolio

13:39 EST 27th January 2019 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

NDC 43093-105-01 Rx only FusePaq™ FANATREX™ (gabapentin 25 mg/mL, in oral suspension - kit) FusePaq™ kits provide a convenient approach to rapidly prepare prescription medications, as all components are pre-measured. This kit is manufactured according to US FDA current Good Manufacturing Practices (cGMP). Description: This kit contains active and inactive bulk materials to prepare 420 mL of a gabapentin oral suspension containing 25 mg/mL gabapentin.  This kit may only be used for the extemporaneous mixing of these ingredients by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient. Contents:

Suggested Preparation Gabapentin, 25 mg/mL oral suspension

1    Remove and Inspect the Contents of the Kit Remove kit contents. Ensure that seals are present and intact on the gabapentin and oral suspension vehicle bottles. If the seals are not intact, do not use the kit.

2    Prepare for Mixing Wear gloves and eye protection during mixing operations. Remove the seal from the oral suspension bottle. Break the seal and remove the cap from the gabapentin bottle.

3    Transfer Gabapentin to the Suspension Bottle Uncap the suspension bottle. Using the included funnel, carefully transfer the gabapentin powder to the suspension bottle. Cap the suspension bottle and mix thoroughly by inverting and shaking until all contents are dissolved. Uncap the suspension bottle. Pour a small amount of the mixed suspension back into the gabapentin bottle. Cap the gabapentin bottle and shake to ensure that all residual gabapentin has been dissolved. Pour the liquid through the funnel into the suspension bottle. Discard the funnel and gabapentin powder bottle.

4    Complete the Mixing Process Insert the press-in bottle adaptor into the suspension bottle. Recap the suspension bottle. Mix well by inverting repeatedly several times. Visually ensure that all contents are dissolved.

5    Re-label the Suspension Label the mixed suspension as required for prescription products. Ensure that the original oral suspension vehicle label is removed or obscured, since the original label is no longer accurate once the suspension is prepared.

Store the unused kit at room temperature of 15-30°C (59-86°F). Once prepared, store the mixed suspension between 15-30°C (59-86°F). The mixed suspension is stable for at least eight weeks, based upon real-time and accelerated stability studies.

Each lot of suspension vehicle is tested to meet microbial limits per USP Microbial Limit Test <61>. In addition, the suspension vehicle formulation has passed the USP <51> Antimicrobial Effectiveness Test. An oral dispenser is provided in the kit and may be used to facilitate delivery of the suspension.

U.S. Patents Pending

Manufactured by: Fusion Pharmaceuticals, LLC 768 Calle Plano Camarillo, CA 93012

CS75-A1 rev 0

Do not use if safety seal is broken Gabapentin 1-(Aminomethyl)cyclohexaneacetic acid CAS #60142-96-3 CAUTION: For manufacturing, processing, repacking, or prescription compounding Net contents: 10.5 g Repackaged by Fusion Pharmaceuticals, LLC Camarillo, CA 93012 CS73-A1 rev 0

Do not use if safety seal is broken For Prescription Compounding Only Oral Suspension Vehicle Dye and paraben free Ingredients: water, banana flavor, N-acetyl-D-glucosamine, strawberry flavor, marshmallow flavor, glycerin, stevia powder, acesulfame potassium, xanthan gum, monoammonium glycyrrhizinate, sodium saccharin, potassium sorbate, sodium benzoate, dibasic sodium phosphate Net Contents: 420 mL (14.2 fl oz) Manufactured for: Fusion Pharmaceuticals, LLC Camarillo, CA 93012 CS74-A1 rev 0

Do not use if safety seal is broken NDC 43093-105-01 Rx only FusePaq™  Kit for Oral Suspension Fanatrex™ (gabapentin 25 mg/mL, in oral suspension - kit) Description: This kit contains active and inactive bulk materials to prepare 420 mL of a gabapentin oral suspension containing 25 mg/mL gabapentin. This kit may only be used for the extemporaneous mixing of these ingredients by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient. Active Ingredient:

Inactive Ingredients:

CAUTION: For manufacturing, processing, repacking, or presciption compounding. Federal law prohibits dispensing without prescription. U.S. Patents Pending CS72-A1 rev 0

Manufacturer

California Pharmaceuticals LLC

Active Ingredients

Source

Clinical Trials [0 Results]

None

PubMed Articles [0 Results]

None

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record